Organization: Health Canada
Year: 2023
Month: September
Request Number: A-2023-000570
Request Summary: With respect to the New Drug Submission for ABSORICA LD, portions of the New Drug Submission that relate to Sun Pharmaceuticals Industries Limited’s ownership, agreement, or contractual rights to the data in the Phase III study referenced in section “14.1 Clinical Trials by Indication".
Disposition: No records exist
Number of pages: 0